Tokyo Tape
Sign in
← Gakken Holdings

Quarterly report · Q2

9470.TEDINET S100QQLT
Period2022-10-01 → 2023-03-31
Filed2023-05-12
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 49
MetricValuePeriodScopeSource row
Revenue¥81.2bn2022-10-01 → 2023-03-31Cons.Net sales
Revenue¥156.0bn2021-10-01 → 2022-09-30Cons.Net sales (5-year summary)
Revenue¥79.6bn2021-10-01 → 2022-03-31Cons.Net sales
Operating income¥3.2bn2022-10-01 → 2023-03-31Cons.Operating income
Operating income¥4.3bn2021-10-01 → 2022-03-31Cons.Operating income
Ordinary income¥3.3bn2022-10-01 → 2023-03-31Cons.Ordinary income
Ordinary income¥6.9bn2021-10-01 → 2022-09-30Cons.Ordinary income loss (5-year summary)
Ordinary income¥4.4bn2021-10-01 → 2022-03-31Cons.Ordinary income
Profit before tax¥2.6bn2022-10-01 → 2023-03-31Cons.Income before income taxes
Profit before tax¥4.4bn2021-10-01 → 2022-03-31Cons.Income before income taxes
Net income (owners)¥1.2bn2022-10-01 → 2023-03-31Cons.Profit loss attributable to owners of parent
Net income (owners)¥3.4bn2021-10-01 → 2022-09-30Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥2.5bn2021-10-01 → 2022-03-31Cons.Profit loss attributable to owners of parent
Net income¥1.3bn2022-10-01 → 2023-03-31Cons.Profit loss
Net income¥2.6bn2021-10-01 → 2022-03-31Cons.Profit loss
Total assets¥132.2bnat 2023-03-31Cons.Assets
Total assets¥123.7bnat 2022-09-30Cons.Assets
Total assets¥129.4bnat 2022-03-31Cons.Total assets (5-year summary)
Total liabilities¥81.6bnat 2023-03-31Cons.Liabilities
Total liabilities¥74.8bnat 2022-09-30Cons.Liabilities
Net assets / equity¥50.6bnat 2023-03-31Cons.Net assets
Net assets / equity¥48.9bnat 2022-09-30Cons.Net assets
Net assets / equity¥49.4bnat 2022-03-31Cons.Net assets (5-year summary)
Cash and deposits¥25.4bnat 2023-03-31Cons.Cash and deposits
Cash and deposits¥22.5bnat 2022-09-30Cons.Cash and deposits
Cash & equivalents¥24.7bnat 2023-03-31Cons.Cash and cash equivalents
Cash & equivalents¥21.7bnat 2022-09-30Cons.Cash and cash equivalents
Cash & equivalents¥20.7bnat 2022-03-31Cons.Cash and cash equivalents
Cash & equivalents¥18.9bnat 2021-09-30dCons.Cash and cash equivalents
Operating cash flow−¥167m2022-10-01 → 2023-03-31Cons.Net cash provided by used in operating activities
Operating cash flow¥5.2bn2021-10-01 → 2022-09-30Cons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow¥676m2021-10-01 → 2022-03-31Cons.Net cash provided by used in operating activities
Investing cash flow−¥1.1bn2022-10-01 → 2023-03-31Cons.Net cash provided by used in investment activities
Investing cash flow−¥5.8bn2021-10-01 → 2022-09-30Cons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow−¥4.2bn2021-10-01 → 2022-03-31Cons.Net cash provided by used in investment activities
Financing cash flow¥4.4bn2022-10-01 → 2023-03-31Cons.Net cash provided by used in financing activities
Financing cash flow¥2.0bn2021-10-01 → 2022-09-30Cons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow¥5.2bn2021-10-01 → 2022-03-31Cons.Net cash provided by used in financing activities
EPS (basic)¥28.152022-10-01 → 2023-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥22.852023-01-01 → 2023-03-31dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥78.672021-10-01 → 2022-09-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥58.392021-10-01 → 2022-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥42.222022-01-01 → 2022-03-31dCons.Basic earnings loss per share (5-year summary)
EPS (diluted)¥27.92022-10-01 → 2023-03-31Cons.Diluted earnings per share (5-year summary)
EPS (diluted)¥77.952021-10-01 → 2022-09-30Cons.Diluted earnings per share (5-year summary)
EPS (diluted)¥57.842021-10-01 → 2022-03-31Cons.Diluted earnings per share (5-year summary)
Equity ratio37.9%at 2023-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio39.2%at 2022-09-30Cons.Equity to asset ratio (5-year summary)
Equity ratio37.8%at 2022-03-31Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 46
SegmentItemPeriodValue
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2022-10-01 → 2023-03-31¥7.5bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2022-10-01 → 2023-03-31¥2.9bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue intersegment2022-10-01 → 2023-03-31¥4.6bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2022-10-01 → 2023-03-31¥294m
Reconciling Itemsreconcilingrevenue2022-10-01 → 2023-03-31−¥4.8bn
Reconciling Itemsreconcilingrevenue intersegment2022-10-01 → 2023-03-31−¥4.8bn
Reconciling Itemsreconcilingsegment profit2022-10-01 → 2023-03-31−¥1.0bn
jpcrp040300-q2r_E00707-000Educationreportable segmentrevenue2022-10-01 → 2023-03-31¥40.3bn
jpcrp040300-q2r_E00707-000Educationreportable segmentrevenue external2022-10-01 → 2023-03-31¥40.2bn
jpcrp040300-q2r_E00707-000Educationreportable segmentrevenue intersegment2022-10-01 → 2023-03-31¥116m
jpcrp040300-q2r_E00707-000Educationreportable segmentsegment profit2022-10-01 → 2023-03-31¥2.6bn
jpcrp040300-q2r_E00707-000Medical Welfarereportable segmentrevenue2022-10-01 → 2023-03-31¥38.1bn
jpcrp040300-q2r_E00707-000Medical Welfarereportable segmentrevenue external2022-10-01 → 2023-03-31¥38.1bn
jpcrp040300-q2r_E00707-000Medical Welfarereportable segmentrevenue intersegment2022-10-01 → 2023-03-31¥42m
jpcrp040300-q2r_E00707-000Medical Welfarereportable segmentsegment profit2022-10-01 → 2023-03-31¥1.4bn
—segment totalrevenue2022-10-01 → 2023-03-31¥78.4bn
—segment totalrevenue external2022-10-01 → 2023-03-31¥78.3bn
—segment totalrevenue intersegment2022-10-01 → 2023-03-31¥158m
—segment totalsegment profit2022-10-01 → 2023-03-31¥3.9bn
Total Of Reportable Segments And Otherssegment totalrevenue2022-10-01 → 2023-03-31¥86.0bn
Total Of Reportable Segments And Otherssegment totalrevenue external2022-10-01 → 2023-03-31¥81.2bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2022-10-01 → 2023-03-31¥4.8bn
Total Of Reportable Segments And Otherssegment totalsegment profit2022-10-01 → 2023-03-31¥4.2bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2021-10-01 → 2022-03-31¥6.9bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2021-10-01 → 2022-03-31¥3.0bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue intersegment2021-10-01 → 2022-03-31¥4.0bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2021-10-01 → 2022-03-31¥532m
Reconciling Itemsreconcilingrevenue2021-10-01 → 2022-03-31−¥4.1bn
Reconciling Itemsreconcilingrevenue intersegment2021-10-01 → 2022-03-31−¥4.1bn
Reconciling Itemsreconcilingsegment profit2021-10-01 → 2022-03-31−¥916m
jpcrp040300-q2r_E00707-000Educationreportable segmentrevenue2021-10-01 → 2022-03-31¥41.6bn
jpcrp040300-q2r_E00707-000Educationreportable segmentrevenue external2021-10-01 → 2022-03-31¥41.4bn
jpcrp040300-q2r_E00707-000Educationreportable segmentrevenue intersegment2021-10-01 → 2022-03-31¥145m
jpcrp040300-q2r_E00707-000Educationreportable segmentsegment profit2021-10-01 → 2022-03-31¥3.5bn
jpcrp040300-q2r_E00707-000Medical Welfarereportable segmentrevenue2021-10-01 → 2022-03-31¥35.2bn
jpcrp040300-q2r_E00707-000Medical Welfarereportable segmentrevenue external2021-10-01 → 2022-03-31¥35.2bn
jpcrp040300-q2r_E00707-000Medical Welfarereportable segmentrevenue intersegment2021-10-01 → 2022-03-31¥24m
jpcrp040300-q2r_E00707-000Medical Welfarereportable segmentsegment profit2021-10-01 → 2022-03-31¥1.2bn
—segment totalrevenue2021-10-01 → 2022-03-31¥76.8bn
—segment totalrevenue external2021-10-01 → 2022-03-31¥76.6bn
—segment totalrevenue intersegment2021-10-01 → 2022-03-31¥169m
—segment totalsegment profit2021-10-01 → 2022-03-31¥4.7bn
Total Of Reportable Segments And Otherssegment totalrevenue2021-10-01 → 2022-03-31¥83.8bn
Total Of Reportable Segments And Otherssegment totalrevenue external2021-10-01 → 2022-03-31¥79.6bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2021-10-01 → 2022-03-31¥4.1bn
Total Of Reportable Segments And Otherssegment totalsegment profit2021-10-01 → 2022-03-31¥5.2bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 535
ItemContextValueUnit
Current liabilitiesPrior1YearInstant39838000000JPY
Current liabilitiesCurrentQuarterInstant44384000000JPY
Bonds payablePrior1YearInstant6000000000JPY
Bonds payableCurrentQuarterInstant6000000000JPY
Long term loans payablePrior1YearInstant19548000000JPY
Long term loans payableCurrentQuarterInstant21804000000JPY
Net defined benefit liabilityPrior1YearInstant3370000000JPY
Net defined benefit liabilityCurrentQuarterInstant3389000000JPY
Other nclPrior1YearInstant6036000000JPY
Other nclCurrentQuarterInstant6004000000JPY
Noncurrent liabilitiesPrior1YearInstant34955000000JPY
Noncurrent liabilitiesCurrentQuarterInstant37197000000JPY
LiabilitiesPrior1YearInstant74793000000JPY
LiabilitiesCurrentQuarterInstant81582000000JPY
Capital stockPrior1YearInstant19817000000JPY
Capital stockCurrentQuarterInstant19817000000JPY
Capital surplusPrior1YearInstant12333000000JPY
Capital surplusCurrentQuarterInstant12357000000JPY
Retained earningsPrior1YearInstant15313000000JPY
Retained earningsCurrentQuarterInstant16024000000JPY
Treasury stockPrior1YearInstant-439000000JPY
Treasury stockCurrentQuarterInstant-322000000JPY
Shareholders equityPrior1YearInstant47025000000JPY
Shareholders equityCurrentQuarterInstant47876000000JPY
Valuation difference on available for sale securitiesPrior1YearInstant612000000JPY
Valuation difference on available for sale securitiesCurrentQuarterInstant1490000000JPY
Deferred gains or losses on hedgesPrior1YearInstant-1000000JPY
Deferred gains or losses on hedgesCurrentQuarterInstant-2000000JPY
Foreign currency translation adjustmentPrior1YearInstant156000000JPY
Foreign currency translation adjustmentCurrentQuarterInstant137000000JPY
Remeasurements of defined benefit plansPrior1YearInstant646000000JPY
Remeasurements of defined benefit plansCurrentQuarterInstant590000000JPY
Valuation and translation adjustmentsPrior1YearInstant1413000000JPY
Valuation and translation adjustmentsCurrentQuarterInstant2216000000JPY
Subscription rights to sharesPrior1YearInstant255000000JPY
Subscription rights to sharesCurrentQuarterInstant234000000JPY
Non controlling interestsPrior1YearInstant193000000JPY
Non controlling interestsCurrentQuarterInstant272000000JPY
Net assetsPrior1YearInstant48888000000JPY
Net assetsCurrentQuarterInstant50600000000JPY
Liabilities and net assetsPrior1YearInstant123682000000JPY
Liabilities and net assetsCurrentQuarterInstant132182000000JPY
Net salesPrior1YTDDuration79632000000JPY
Net salesCurrentYTDDuration81174000000JPY
Cost of salesPrior1YTDDuration55609000000JPY
Cost of salesCurrentYTDDuration57567000000JPY
Gross profitPrior1YTDDuration24023000000JPY
Gross profitCurrentYTDDuration23606000000JPY
Selling general and administrative expensesPrior1YTDDuration19698000000JPY
Selling general and administrative expensesCurrentYTDDuration20381000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 14 of 14 passed
balance sheet identityconsolidated 2022-09-30pass rounding
balance sheet identityconsolidated 2023-03-31pass
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2022-09-30pass
statement vs summary · net assetsconsolidated 2023-03-31pass
statement vs summary · net income attributable to parentconsolidated 2021-10-01/2022-03-31pass
statement vs summary · net income attributable to parentconsolidated 2022-10-01/2023-03-31pass
statement vs summary · operating cash flowconsolidated 2021-10-01/2022-03-31pass
statement vs summary · operating cash flowconsolidated 2022-10-01/2023-03-31pass
statement vs summary · revenueconsolidated 2021-10-01/2022-03-31pass
statement vs summary · revenueconsolidated 2022-10-01/2023-03-31pass
statement vs summary · total assetsconsolidated 2022-09-30pass
statement vs summary · total assetsconsolidated 2023-03-31pass